Highlights from the opening day of the 2014 European Huntington's Disease network in Barcelona, Spain
The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?
An important new study asks the question: what parts of the brain might need most help in HD?
Does a specific amino acid deficiency contribute to the development of HD?
New studies shed some light on the function of sleep in animals, with interesting implications for HD research
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?
A new study claims that high-dose creatine "slows the onset of Huntington Disease". How much hope and how much hype?
Researchers identify Gpx1, a protein that may be protective in HD. An existing drug can mimic its antioxidant effect.
There is copper in your brain! Check out how copper and the Huntington’s disease protein are partners in crime.